| Year |
Citation |
Score |
| 2023 |
Turner JS, McCabe EA, Kuang KW, Gailey CD, Brautigan DL, Limerick A, Wang EX, Fu Z. The Scaffold Protein KATNIP Enhances CILK1 Control of Primary Cilia. Molecular and Cellular Biology. 43: 472-480. PMID 37665596 DOI: 10.1080/10985549.2023.2246870 |
0.312 |
|
| 2021 |
Brautigan DL, Farrington C, Narla G. Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents. Clinical Science (London, England : 1979). 135: 1545-1556. PMID 34192314 DOI: 10.1042/CS20201367 |
0.331 |
|
| 2020 |
Heo J, Larner JM, Brautigan DL. Protein kinase CK2 phosphorylation of SAPS3 subunit increases PP6 phosphatase activity with Aurora A kinase. The Biochemical Journal. PMID 31904830 DOI: 10.1042/Bcj20190740 |
0.357 |
|
| 2019 |
Oh YS, Wang EJ, Gailey CD, Brautigan DL, Allen BL, Fu Z. Ciliopathy-Associated Protein Kinase ICK Requires Its Non-Catalytic Carboxyl-Terminal Domain for Regulation of Ciliogenesis. Cells. 8. PMID 31277411 DOI: 10.3390/Cells8070677 |
0.317 |
|
| 2017 |
Sangodkar J, Perl A, Tohme R, Kiselar J, Kastrinsky DB, Zaware N, Izadmehr S, Mazhar S, Wiredja DD, O'Connor CM, Hoon D, Dhawan NS, Schlatzer D, Yao S, Leonard D, ... ... Brautigan DL, et al. Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth. The Journal of Clinical Investigation. PMID 28504649 DOI: 10.1172/Jci89548 |
0.309 |
|
| 2016 |
Sangodkar J, Tohme R, Kiselar J, Izadmehr S, Hoon D, Mazhar S, Perl A, Wiredja D, Schlatzer D, Yao S, Kastrinsky D, Sharma N, Brautigan D, Chance M, Borczuk A, et al. Abstract 3865: Therapeutic activation of protein phosphatase 2A for the treatment of lung cancer Cancer Research. 76: 3865-3865. DOI: 10.1158/1538-7445.Am2016-3865 |
0.336 |
|
| 2013 |
Brautigan DL. Protein Ser/Thr phosphatases--the ugly ducklings of cell signalling. The Febs Journal. 280: 324-45. PMID 22519956 DOI: 10.1111/J.1742-4658.2012.08609.X |
0.331 |
|
| 2012 |
Eto M, Brautigan DL. Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling. Iubmb Life. 64: 732-9. PMID 22815089 DOI: 10.1002/Iub.1067 |
0.386 |
|
| 2011 |
Martín-Montalvo A, González-Mariscal I, Padilla S, Ballesteros M, Brautigan DL, Navas P, Santos-Ocaña C. Respiratory-induced coenzyme Q biosynthesis is regulated by a phosphorylation cycle of Cat5p/Coq7p. The Biochemical Journal. 440: 107-14. PMID 21812761 DOI: 10.1042/Bj20101422 |
0.315 |
|
| 2010 |
Wang H, Owens C, Chandra N, Conaway MR, Brautigan DL, Theodorescu D. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis. Cancer Research. 70: 8760-9. PMID 20940393 DOI: 10.1158/0008-5472.Can-10-0952 |
0.328 |
|
| 2010 |
Hall EH, Balsbaugh JL, Rose KL, Shabanowitz J, Hunt DF, Brautigan DL. Comprehensive analysis of phosphorylation sites in Tensin1 reveals regulation by p38MAPK. Molecular & Cellular Proteomics : McP. 9: 2853-63. PMID 20798394 DOI: 10.1074/Mcp.M110.003665 |
0.335 |
|
| 2010 |
Broglie P, Matsumoto K, Akira S, Brautigan DL, Ninomiya-Tsuji J. Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway. The Journal of Biological Chemistry. 285: 2333-9. PMID 19955178 DOI: 10.1074/Jbc.M109.090522 |
0.311 |
|
| 2008 |
Prickett TD, Ninomiya-Tsuji J, Broglie P, Muratore-Schroeder TL, Shabanowitz J, Hunt DF, Brautigan DL. TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB. The Journal of Biological Chemistry. 283: 19245-54. PMID 18456659 DOI: 10.1074/Jbc.M800943200 |
0.314 |
|
| 2007 |
Eto M, Kitazawa T, Matsuzawa F, Aikawa Si, Kirkbride JA, Isozumi N, Nishimura Y, Brautigan DL, Ohki Sy. Phosphorylation-Induced Conformational Switching of CPI-17 Produces a Potent Myosin Phosphatase Inhibitor Structure. 15: 1591-1602. PMID 18073109 DOI: 10.1016/J.Str.2007.10.014 |
0.354 |
|
| 2007 |
Li M, Satinover DL, Brautigan DL. Phosphorylation and functions of inhibitor-2 family of proteins. Biochemistry. 46: 2380-9. PMID 17286390 DOI: 10.1021/Bi602369M |
0.364 |
|
| 2006 |
Kajino T, Ren H, Iemura S, Natsume T, Stefansson B, Brautigan DL, Matsumoto K, Ninomiya-Tsuji J. Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. The Journal of Biological Chemistry. 281: 39891-6. PMID 17079228 DOI: 10.1074/Jbc.M608155200 |
0.341 |
|
| 2006 |
Li M, Stefansson B, Wang W, Schaefer EM, Brautigan DL. Phosphorylation of the Pro-X-Thr-Pro site in phosphatase inhibitor-2 by cyclin-dependent protein kinase during M-phase of the cell cycle. Cellular Signalling. 18: 1318-26. PMID 16377132 DOI: 10.1016/J.Cellsig.2005.10.020 |
0.335 |
|
| 2006 |
Brautigan D. Protein phosphatase inhibitor-2 Afcs-Nature Molecule Pages. DOI: 10.1038/Mp.A001939.01 |
0.363 |
|
| 2004 |
Eto M, Kitazawa T, Brautigan DL. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proceedings of the National Academy of Sciences of the United States of America. 101: 8888-93. PMID 15184667 DOI: 10.1073/Pnas.0307812101 |
0.316 |
|
| 2004 |
Satinover DL, Leach CA, Stukenberg PT, Brautigan DL. Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein. Proceedings of the National Academy of Sciences of the United States of America. 101: 8625-30. PMID 15173575 DOI: 10.1073/Pnas.0402966101 |
0.391 |
|
| 2003 |
Eto M, Leach C, Tountas NA, Brautigan DL. Phosphoprotein inhibitors of protein phosphatase-1. Methods in Enzymology. 366: 243-60. PMID 14674253 DOI: 10.1016/S0076-6879(03)66019-2 |
0.347 |
|
| 2003 |
Erdodi F, Kiss E, Walsh MP, Stefansson B, Deng JT, Eto M, Brautigan DL, Hartshorne DJ. Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases. Biochemical and Biophysical Research Communications. 306: 382-7. PMID 12804574 DOI: 10.1016/S0006-291X(03)00976-8 |
0.347 |
|
| 2003 |
Murthy KS, Zhou H, Grider JR, Brautigan DL, Eto M, Makhlouf GM. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. The Biochemical Journal. 374: 145-55. PMID 12733988 DOI: 10.1042/Bj20021274 |
0.336 |
|
| 2003 |
Leach C, Shenolikar S, Brautigan DL. Phosphorylation of phosphatase inhibitor-2 at centrosomes during mitosis. The Journal of Biological Chemistry. 278: 26015-20. PMID 12697755 DOI: 10.1074/Jbc.M300782200 |
0.329 |
|
| 2002 |
Wang H, Brautigan DL. A novel transmembrane Ser/Thr kinase complexes with protein phosphatase-1 and inhibitor-2. The Journal of Biological Chemistry. 277: 49605-12. PMID 12393858 DOI: 10.1074/Jbc.M209335200 |
0.341 |
|
| 2002 |
Eto M, Elliott E, Prickett TD, Brautigan DL. Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation. The Journal of Biological Chemistry. 277: 44013-20. PMID 12221103 DOI: 10.1074/Jbc.M208035200 |
0.344 |
|
| 2002 |
Guo CY, Brautigan DL, Larner JM. Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation. The Journal of Biological Chemistry. 277: 41756-61. PMID 12202491 DOI: 10.1074/Jbc.M207519200 |
0.331 |
|
| 2002 |
Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. The Biochemical Journal. 367: 517-24. PMID 12144526 DOI: 10.1042/Bj20020522 |
0.332 |
|
| 2002 |
Zhou B, Wang ZX, Zhao Y, Brautigan DL, Zhang ZY. The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. The Journal of Biological Chemistry. 277: 31818-25. PMID 12082107 DOI: 10.1074/Jbc.M203969200 |
0.356 |
|
| 2002 |
Ohki S, Eto M, Kariya E, Hayano T, Hayashi Y, Yazawa M, Brautigan D, Kainosho M. Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation. Journal of Molecular Biology. 314: 839-49. PMID 11734001 DOI: 10.1006/Jmbi.2001.5200 |
0.383 |
|
| 2002 |
Broustas CG, Grammatikakis N, Eto M, Dent P, Brautigan DL, Kasid U. Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity. The Journal of Biological Chemistry. 277: 3053-9. PMID 11719507 DOI: 10.1074/Jbc.M106343200 |
0.369 |
|
| 2001 |
Everett AD, Stoops TD, Nairn AC, Brautigan D. Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes. American Journal of Physiology. Heart and Circulatory Physiology. 281: H161-7. PMID 11406481 DOI: 10.1152/Ajpheart.2001.281.1.H161 |
0.368 |
|
| 1992 |
Suganuma M, Fujiki H, Okabe S, Nishiwaki S, Brautigan D, Ingebritsen TS, Rosner MR. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon : Official Journal of the International Society On Toxinology. 30: 873-8. PMID 1326138 DOI: 10.1016/0041-0101(92)90385-I |
0.357 |
|
| 1991 |
Chung SK, Reinhart PH, Martin BL, Brautigan D, Levitan IB. Protein kinase activity closely associated with a reconstituted calcium-activated potassium channel. Science (New York, N.Y.). 253: 560-2. PMID 1857986 DOI: 10.1126/Science.1857986 |
0.353 |
|
| Show low-probability matches. |